New study tracks eye disease in rare genetic disorder
NCT ID NCT06190626
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 30 people with Zellweger Spectrum Disorder over 5 years to understand how their vision changes over time. Participants will have yearly vision tests, physical exams, and blood work. The goal is to define the course of retinal degeneration and find the best ways to monitor it.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could provide doctors and families with clear information on how vision loss progresses in Zellweger Spectrum Disorder and which tests best track it.
- What could go wrong
- This is an observational study with only 30 participants, so findings may not apply to all patients. It does not test any treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ZELLWEGER SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Eye Institute of Alberta
RECRUITINGEdmonton, Alberta, T5H 3V9, Canada
-
Research Institute-McGill University Health Center
RECRUITINGMontreal, Quebec, H4A 3J1, Canada
-
University of Rochester Medical Center/Flaum Eye Institute
RECRUITINGRochester, New York, 14642, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.